BRPI0408561A - métodos para manufatura de 2'-desoxi-59-l-nucleosìeos - Google Patents
métodos para manufatura de 2'-desoxi-59-l-nucleosìeosInfo
- Publication number
- BRPI0408561A BRPI0408561A BRPI0408561-2A BRPI0408561A BRPI0408561A BR PI0408561 A BRPI0408561 A BR PI0408561A BR PI0408561 A BRPI0408561 A BR PI0408561A BR PI0408561 A BRPI0408561 A BR PI0408561A
- Authority
- BR
- Brazil
- Prior art keywords
- deoxy
- manufacturing
- methods
- nucleosides
- prodrugs
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000002777 nucleoside Substances 0.000 title 1
- 229940002612 prodrug Drugs 0.000 abstract 2
- 239000000651 prodrug Substances 0.000 abstract 2
- IBNJYMSLQFJRQV-UHFFFAOYSA-N 2-chloro-1-(6-fluoro-2-methyl-3,4-dihydro-2h-quinolin-1-yl)ethanone Chemical compound FC1=CC=C2N(C(=O)CCl)C(C)CCC2=C1 IBNJYMSLQFJRQV-UHFFFAOYSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 229960005311 telbivudine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/02—Monosaccharides
Abstract
"MéTODOS PARA MANUFATURA DE 2<39>-DESOXI-<225>-L-NUCLEOSìDEOS". A presente invenção está relacionada à sintese de 2<39>1desoxi-<39>-L-timidina, 2<39>-desoxi-<225>-L-uridina e 2<39>-desoxi-<225>-Lcitidina, e seus derivados, como pró-medicamentos- de 3<39> -0acil ou 3<39>,5<39>-0-diacil, que incluem os pró-medicamentos 3<39>O-L-aminoacil e 3<39>,5<39>-0-L-diaminoacil, e particularmente os pró-medicamentos 3<39>-0-L-valinil e 3<39>,5<39>-0-L-divalinil.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45646503P | 2003-03-20 | 2003-03-20 | |
PCT/IB2004/001308 WO2004084453A2 (en) | 2003-03-20 | 2004-03-22 | METHODS OF MANUFACTURE OF 2'-DEOXY-β-L-NUCLEOSIDES |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0408561A true BRPI0408561A (pt) | 2006-03-21 |
Family
ID=33030097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0408561-2A BRPI0408561A (pt) | 2003-03-20 | 2004-03-22 | métodos para manufatura de 2'-desoxi-59-l-nucleosìeos |
Country Status (6)
Country | Link |
---|---|
US (1) | US7582748B2 (pt) |
EP (1) | EP1745573A4 (pt) |
KR (1) | KR20060008297A (pt) |
CN (1) | CN101415719A (pt) |
BR (1) | BRPI0408561A (pt) |
WO (1) | WO2004084453A2 (pt) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
KR20080021797A (ko) | 2000-05-26 | 2008-03-07 | 이데닉스(케이만)리미티드 | 플라비바이러스 및 페스티바이러스의 치료방법 및 조성물 |
PL374781A1 (en) | 2002-06-28 | 2005-10-31 | Idenix (Cayman) Limited | 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
US7608600B2 (en) | 2002-06-28 | 2009-10-27 | Idenix Pharmaceuticals, Inc. | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections |
EP1576138B1 (en) | 2002-11-15 | 2017-02-01 | Idenix Pharmaceuticals LLC. | 2'-methyl nucleosides in combination with interferon and flaviviridae mutation |
WO2004096149A2 (en) * | 2003-04-28 | 2004-11-11 | Idenix (Cayman) Limited | Industrially scalable nucleoside synthesis |
BR122018015050B1 (pt) | 2003-05-30 | 2021-07-13 | Gilead Pharmasset Llc | Derivados fosfatados de nucleosídeo e composição farmacêutica dos mesmos |
KR20060035652A (ko) * | 2003-06-30 | 2006-04-26 | 이데닉스 (케이만) 리미티드 | β-L-2-데옥시 뉴클레오시드의 합성 |
CN101023094B (zh) | 2004-07-21 | 2011-05-18 | 法莫赛特股份有限公司 | 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备 |
ES2725457T3 (es) | 2004-09-14 | 2019-09-24 | Gilead Pharmasset Llc | Preparación de ribofuranosil pirimidinas y purinas 2'fluoro-2'-alquil-sustituidas u otras opcionalmente sustituidas y sus derivados |
US7781576B2 (en) | 2005-12-23 | 2010-08-24 | Idenix Pharmaceuticals, Inc. | Process for preparing a synthetic intermediate for preparation of branched nucleosides |
GB0609178D0 (en) | 2006-05-09 | 2006-06-21 | Univ Cardiff | Novel compounds |
US7964580B2 (en) | 2007-03-30 | 2011-06-21 | Pharmasset, Inc. | Nucleoside phosphoramidate prodrugs |
US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
CN102209467B (zh) * | 2008-10-03 | 2014-03-12 | 台湾神隆股份有限公司 | 地西他滨(Decitabine)的合成 |
US8586729B2 (en) * | 2008-10-03 | 2013-11-19 | Scinopharm Taiwan Ltd. | Synthesis of decitabine |
KR20110104074A (ko) | 2008-12-23 | 2011-09-21 | 파마셋 인코포레이티드 | 퓨린 뉴클레오시드의 합성 |
AU2009329867B2 (en) | 2008-12-23 | 2015-01-29 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
CN102753563A (zh) | 2008-12-23 | 2012-10-24 | 吉利德制药有限责任公司 | 核苷类似物 |
TWI576352B (zh) | 2009-05-20 | 2017-04-01 | 基利法瑪席特有限責任公司 | 核苷磷醯胺 |
US8618076B2 (en) | 2009-05-20 | 2013-12-31 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
EP2752422B1 (en) | 2010-03-31 | 2017-08-16 | Gilead Pharmasset LLC | Stereoselective synthesis of phosphorus containing actives |
US8563530B2 (en) | 2010-03-31 | 2013-10-22 | Gilead Pharmassel LLC | Purine nucleoside phosphoramidate |
KR101241321B1 (ko) * | 2010-08-05 | 2013-03-11 | 케이피엑스 라이프사이언스 주식회사 | 수율 및 순도가 개선된 데시타빈의 제조방법 |
EP2646453A1 (en) | 2010-11-30 | 2013-10-09 | Gilead Pharmasset LLC | Compounds |
US8889159B2 (en) | 2011-11-29 | 2014-11-18 | Gilead Pharmasset Llc | Compositions and methods for treating hepatitis C virus |
EP3038601B1 (en) | 2013-08-27 | 2020-04-08 | Gilead Pharmasset LLC | Combination formulation of two antiviral compounds |
CN104744538A (zh) * | 2013-12-26 | 2015-07-01 | 康普药业股份有限公司 | 一种替比夫定的制备方法 |
CN104059057A (zh) * | 2014-01-03 | 2014-09-24 | 石家庄龙泽制药有限公司 | 拉米夫定杂质3-tu的制备方法 |
CN104356186B (zh) * | 2014-10-24 | 2017-03-15 | 济南尚博生物科技有限公司 | 一种3’,5’‑二‑氧‑(4‑对甲基苯甲酰基)‑β‑L‑胸腺嘧啶的制备方法 |
CN106478752B (zh) * | 2015-09-01 | 2019-10-25 | 四川科伦药物研究院有限公司 | 一种替比夫定的制备方法 |
MX2018002707A (es) * | 2015-09-02 | 2018-08-01 | Abbvie Inc | Derivados de tetrahidrofurano antivirales. |
CN108299518A (zh) * | 2018-02-02 | 2018-07-20 | 王成宇 | 一种2`-脱氧-β-尿苷的合成方法 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2122991C2 (de) * | 1971-05-04 | 1982-06-09 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von Cytosin- und 6-Azacytosinnucleosiden |
DD140254A1 (de) | 1978-12-04 | 1980-02-20 | Dieter Baerwolff | Verfahren zur herstellung von 4-substituierten pyrimidin-nucleosiden |
US4754026A (en) * | 1985-06-04 | 1988-06-28 | Takeda Chemical Industries, Ltd. | Conversion of uracil derivatives to cytosine derivatives |
EP0311694B1 (en) * | 1987-04-23 | 1995-12-13 | Rikagaku Kenkyusho | Nucleoside derivatives and process for their preparation |
GB8719367D0 (en) * | 1987-08-15 | 1987-09-23 | Wellcome Found | Therapeutic compounds |
SE8802687D0 (sv) | 1988-07-20 | 1988-07-20 | Astra Ab | Nucleoside derivatives |
US5358936A (en) * | 1990-08-03 | 1994-10-25 | Paul Gordon | Anionic furanose derivatives, methods of making and using the same |
DE4224737A1 (de) | 1992-07-27 | 1994-02-03 | Herbert Prof Dr Schott | Neue Cytosinnucleosidanaloga, Verfahren zu ihrer Herstellung und ihre Verwendung |
GB9307043D0 (en) * | 1993-04-05 | 1993-05-26 | Norsk Hydro As | Chemical compounds |
JP3693357B2 (ja) | 1993-04-09 | 2005-09-07 | 峯郎 実吉 | 逆転写酵素阻害剤 |
FR2709754B1 (fr) | 1993-09-10 | 1995-12-01 | Centre Nat Rech Scient | Composés 2' ou 3'-déoxy- et 2', 3'-didéoxy-beta-L-pentofuranonucléosides, procédé de préparation et application thérapeutique, notamment anti-virale. |
US5587362A (en) * | 1994-01-28 | 1996-12-24 | Univ. Of Ga Research Foundation | L-nucleosides |
JPH07224081A (ja) | 1994-02-10 | 1995-08-22 | Kobayashi Koryo Kk | デオキシリボフラノシルハライド誘導体の製造方法 |
WO1996011204A1 (de) | 1994-10-07 | 1996-04-18 | Max-Delbrück-Centrum für Molekulare Medizin | NEUE β-L-NUCLEOSIDE UND IHRE VERWENDUNG |
US5559101A (en) | 1994-10-24 | 1996-09-24 | Genencor International, Inc. | L-ribofuranosyl nucleosides |
PT831852E (pt) | 1995-06-07 | 2007-02-28 | Uab Research Foundation | Nucleósidos com actividade anti-vírus da hepatite b |
AU709345B2 (en) * | 1995-09-07 | 1999-08-26 | Emory University | Therapeutic azide compounds |
US6248878B1 (en) * | 1996-12-24 | 2001-06-19 | Ribozyme Pharmaceuticals, Inc. | Nucleoside analogs |
US6444652B1 (en) * | 1998-08-10 | 2002-09-03 | Novirio Pharmaceuticals Limited | β-L-2'-deoxy-nucleosides for the treatment of hepatitis B |
AU5475799A (en) * | 1998-08-10 | 2000-03-06 | Centre National De La Recherche Scientifique | Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis |
JP4067226B2 (ja) | 1999-04-01 | 2008-03-26 | 三井化学株式会社 | 1―ハロゲノ−2−デオキシリボフラノース誘導体の製造方法 |
WO2001058917A1 (fr) * | 2000-02-10 | 2001-08-16 | Mitsui Chemicals, Inc. | Procede de preparation de derives de trifluorothymidine |
MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
US6875751B2 (en) * | 2000-06-15 | 2005-04-05 | Idenix Pharmaceuticals, Inc. | 3′-prodrugs of 2′-deoxy-β-L-nucleosides |
MY141594A (en) | 2000-06-15 | 2010-05-14 | Novirio Pharmaceuticals Ltd | 3'-PRODRUGS OF 2'-DEOXY-ß-L-NUCLEOSIDES |
JP2005536440A (ja) * | 2001-09-28 | 2005-12-02 | イデニクス(ケイマン)リミテツド | 4’位が修飾されたヌクレオシドを使用するフラビウイルスおよびペスチウイルスの治療のための方法および組成物 |
JP5116972B2 (ja) * | 2002-12-12 | 2013-01-09 | イデニクス(ケイマン)リミテツド | 2’−分枝ヌクレオシドの製造方法 |
-
2004
- 2004-03-22 CN CNA2004800129619A patent/CN101415719A/zh active Pending
- 2004-03-22 KR KR1020057017617A patent/KR20060008297A/ko not_active Application Discontinuation
- 2004-03-22 BR BRPI0408561-2A patent/BRPI0408561A/pt not_active IP Right Cessation
- 2004-03-22 EP EP04722357A patent/EP1745573A4/en not_active Withdrawn
- 2004-03-22 WO PCT/IB2004/001308 patent/WO2004084453A2/en active Application Filing
- 2004-03-22 US US10/806,296 patent/US7582748B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
KR20060008297A (ko) | 2006-01-26 |
EP1745573A2 (en) | 2007-01-24 |
US20040266996A1 (en) | 2004-12-30 |
CN101415719A (zh) | 2009-04-22 |
EP1745573A4 (en) | 2010-05-26 |
US7582748B2 (en) | 2009-09-01 |
WO2004084453A2 (en) | 2004-09-30 |
WO2004084453A3 (en) | 2009-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0408561A (pt) | métodos para manufatura de 2'-desoxi-59-l-nucleosìeos | |
BR0315296A (pt) | Derivados do ciclohexanol espirocìclicos | |
BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
UY29927A1 (es) | Derivados sustituidos de la 5-fenil-2-tioxo-imidazolin-4-ona y de la 5-fenil-2-amino-imidazolidin-4-ona y sus sales, composiciones y aplicaciones | |
UY29919A1 (es) | Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones | |
PA8595901A1 (es) | "n-arilheterociclos sustituidos, procedimientos para su preparacion, y su empleo como medicamentos | |
ECSP067043A (es) | Derivados de pirrolotriazina útiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogénesis | |
HN2006019068A (es) | "sintesis de (r)-n-metilnaltrexona" | |
BRPI0408347B8 (pt) | derivados de pirimidina, seu uso, e composição e combinação farmacêuticas | |
CR9223A (es) | 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen | |
BRPI0519710A2 (pt) | aminoÁlcoois tricÍclicos, processo para sua preparaÇço e seu emprego como anti-inflamatàrio | |
PA8667201A1 (es) | Nuevos compuestos farmaceuticos | |
CY1111206T1 (el) | Βενζοθειοφαινια υποκατεστημενα με πιπεραζινη για την αγωγη διανοητικων διαταραχων | |
BRPI0418031A (pt) | inibidores de quinase fosfonato-substituìdos | |
BRPI0411528A (pt) | uso de isomalte como prebiótico | |
UY30025A1 (es) | Derivados sustituidos de las 2-amino-5,6-dihidro pirimidin-4(3h)-onas y sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones. | |
BR0211521A (pt) | Derivados de retinóide com atividades antiangiogênicas, antitumorais e pró-apoptóticas | |
CR9182A (es) | Derivado de quinolina, su uso, preparacion y medicamento que lo contiene | |
ECSP066291A (es) | Sistemas emulsionantes que contienen derivados de azetidina | |
BRPI0518841A2 (pt) | derivados de indenila e uso destes para o tratamento de transtornos neurolàgicos | |
BRPI0415203A (pt) | pentanóis reestruturados, um processo para sua produção e seu uso como agentes antiinflamatórios | |
BRPI0406824A (pt) | Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm | |
BR0317284A (pt) | Inibidores aminocianopiridina de proteìna quinase-2 ativada com proteìna quinase ativada com mitógeno | |
UY29417A1 (es) | Agentes endoparasiticidas | |
PA8589801A1 (es) | Aminoalcoxiindoles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |